Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Select your species
This study suggests that aberrant activity of TAK1 impairs autophagy and subsequently leads to alterations in the vitality of retinal pigment epithelial cells.
TAK1 may be an important factor involved in the pathogenesis of thyroid cancer, and targeted down-regulation of TAK1 may improve the prognosis of patients with thyroid cancer.
Loss of MAP3K7 are associated with esophageal squamous cell carcinoma.
This paper highlights that targeting the BMP and TGFbeta (Montrer TGFB1 Kits ELISA) type I and type II receptors causes a downregulation of XIAP (Montrer XIAP Kits ELISA), TAK1, and Id1 (Montrer ID1 Kits ELISA) leading to cell death of lung cancer cells.
Polyubiquitination of Transforming Growth Factor beta-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4 (Montrer TLR4 Kits ELISA)-mediated JNK (Montrer MAPK8 Kits ELISA) and p38 MAPK (Montrer MAPK14 Kits ELISA) Activation
The data emphasize the central role of TAK1 in controlling signaling cascades and functional responses in primary neutrophils, making it a promising target for therapeutic intervention in view of the role of neutrophils in chronic inflammatory conditions.
MiR (Montrer MLXIP Kits ELISA)-377 is an important negative regulator of E2F (Montrer E2F1 Kits ELISA) and MAP3K7/NF-kB signaling pathway in melanoma cells.
the TAK1 signaling pathway may represent a suitable target to design new, antifibrotic therapies
Findings indicate that SHIP2 (Montrer INPPL1 Kits ELISA) is a regulator of lymphatic function in humans and that inherited mutations in the INPPL1 (Montrer INPPL1 Kits ELISA) gene may act in concert with HGF (Montrer HGF Kits ELISA), and likely MAP3K7, mutations to exacerbate lymphatic phenotypes.
Data indicate that inhibition of TGF-beta (Montrer TGFB1 Kits ELISA)-activated protein kinase (Montrer CDK7 Kits ELISA) 1 (TAK1) reduces chemokine (C-C motif) receptor 7 (CCR7 (Montrer CCR7 Kits ELISA)) expression.
TAK1 (Montrer NR2C2 Kits ELISA) signaling preserved the viability of lambda-chain-positive B cells by maintaining Bcl-2 (Montrer BCL2 Kits ELISA) expression through IKK (Montrer CHUK Kits ELISA)-NF-kappaB (Montrer NFKB1 Kits ELISA) signaling
Data show that TGFbeta (Montrer TGFB1 Kits ELISA)-activated kinase-1 (TAK1 (Montrer NR2C2 Kits ELISA)) activated nuclear factor of activated T-cells (NFAT (Montrer NFATC1 Kits ELISA))/NF-kappa B (NFkappaB (Montrer NFKB1 Kits ELISA)), downregulated BCL2-adenovirus E1B interacting protein 3 (Bnip3 (Montrer BNIP3 Kits ELISA)), and inhibited cardiac cell death.
Crucial functions of inflammatory TAK1 (Montrer NR2C2 Kits ELISA)-NEMO (Montrer IKBKG Kits ELISA) signaling in protecting the brain endothelium and maintaining normal brain function.
Roles of TAK1 (Montrer NR2C2 Kits ELISA) in vascular oxidative stress and its contribution to neointima formation after vascular injury.
Inactivation of TAK1 (Montrer NR2C2 Kits ELISA) in satellite cells inhibits muscle regeneration in adult mice.
our current study highlighted the emerging role of TAK1 (Montrer NR2C2 Kits ELISA) in configuring the gut (Montrer GUSB Kits ELISA)-specialized T cell subset, which regulates mucosal homeostasis under lymphopenic conditions.
the ADAP (Montrer APP Kits ELISA) CARMA1 (Montrer CARD11 Kits ELISA) binding site is required for IKK gamma (Montrer IKBKG Kits ELISA) ubiquitination; both TAK1 (Montrer NR2C2 Kits ELISA) and CARMA1 (Montrer CARD11 Kits ELISA) binding sites are required for IkappaB alpha (Montrer NFKBIA Kits ELISA) phosphorylation and degradation and NF-kappaB (Montrer NFKB1 Kits ELISA) nuclear translocation
Results provide evidence that TAK1 (Montrer NR2C2 Kits ELISA) is required for the activation of NF-kappaB (Montrer NFKB1 Kits ELISA) in thymocytes and suggest that TAK1 (Montrer NR2C2 Kits ELISA) plays a central role in both innate and adaptive immunity.
TAK1 (Montrer NR2C2 Kits ELISA) is essential for connective tissue deposition in the dermis.
Tak1 functions to regulate tongue development by controlling Fgf10 expression and could represent a candidate gene for mutation in human PRS clefting.
The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP), and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1, this protein forms a kinase complex including TRAF6, MAP3K7P1/TAB1 and MAP3K7P2/TAB2\; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK, MAP2K4/MKK4, and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported.
mitogen-activated protein kinase kinase kinase 7
, TGF-beta-activated kinase TAK1
, TGF-beta activated kinase 1
, TGF-beta-activated kinase 1
, transforming growth factor-beta-activated kinase 1
, mitogen activated protein kinase kinase kinase 7
, transforming growth factor beta-activated kinase 1